Effect of adjuvant carboplatin intensified chemotherapy versus standard chemotherapy on survival in women with high risk, early stage, triple negative breast cancer (CITRINE): randomised, open label phase 3 trial
Yin Liu, Yue Gong, Xiu-Zhi Zhu, Guang-Yu Liu, Ke-Da Yu, Fan Yang, Li Chen, Min He, Zhen Hu, Can-Ming Chen, A-Yong Cao, Jun-Jie Li, Yi-Feng Hou, Gen-Hong Di, Jiong Wu, Yi-Zhou Jiang, Lei Fan, Zhong-Hua Wang, Zhi-Ming Shao · 2025
Read Effect of adjuvant carboplatin intensified chemotherapy versus standard chemotherapy on survival in women with high risk, early stage, triple negative breast cancer (CITRINE): randomised, open label phase 3 trial by Yin Liu, Yue Gong, Xiu-Zhi Zhu, Guang-Yu Liu, Ke-Da Yu, Fan Yang, Li Chen, Min He, Zhen Hu, Can-Ming Chen, A-Yong Cao, Jun-Jie Li, Yi-Feng Hou, Gen-Hong Di, Jiong Wu, Yi-Zhou Jiang, Lei Fan, Zhong-Hua Wang, Zhi-Ming Shao (2025) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-12723525.txt.
Description
Yin Liu leads a team reporting the CITRINE trial on intensified chemotherapy for dangerous early breast cancer, published in two thousand twenty-five. Triple negative cancers lack the usual drug targets. High-risk patients, with involved nodes or fast-dividing tumors, need better post-surgery treatment.
The randomized phase three trial ran at a Shanghai cancer center from two thousand twenty to two thousand twenty-two. Women received standard epirubicin, cyclophosphamide, and weekly paclitaxel, with or without added carboplatin. The design was open label, with survival as the key measure. Adding platinum drugs is a long-debated intensification strategy in this disease. The paper reports whether the extra drug, and its extra toxicity, bought longer life.
Catalog record
| CREATOR | Yin Liu, Yue Gong, Xiu-Zhi Zhu, Guang-Yu Liu, Ke-Da Yu, Fan Yang, Li Chen, Min He, Zhen Hu, Can-Ming Chen, A-Yong Cao, Jun-Jie Li, Yi-Feng Hou, Gen-Hong Di, Jiong Wu, Yi-Zhou Jiang, Lei Fan, Zhong-Hua Wang, Zhi-Ming Shao |
|---|---|
| YEAR | 2025 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 47 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |